State of the Art Speakers

  Fay Betsou, PhD, HDR
Dr. Betsou is Chief Scientific Officer at Integrated Biobank of Luxembourg (IBBL), where she directs activities of the Biorefinery and Biospecimen Research Laboratory. She is a molecular biologist with 20 years of experience in molecular diagnostics, disease-oriented biobanking, biospecimen research, and certification and accreditation applied to biobanks. She holds four patents and is the author of more than 90 peer-reviewed publications, most focused on biospecimen research. She is a Past President of International Society for Biological and Environmental Repositories (ISBER), and Chair of the ISBER Biospecimen Science Working Group and the Proficiency Testing Taskforce. She is a national delegate in ISO REMCO and ISO TC276, and an Associate Professor at the University of Luxembourg.
  Antonia M. Calafat, PhD
Antonia Calafat is the Chief of the Organic Analytical Toxicology Branch at the Division of Laboratory Sciences, National Center for Environmental Health of the US Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia. She earned her Bachelor, Master, and Doctoral degrees in Chemistry from the University of the Balearic Islands (Spain). Prior to her career at CDC, she was a Fulbright Scholar and a Research Associate at Emory University. She currently leads CDC’s biomonitoring programs for assessing human exposure to pesticides; polycyclic aromatic hydrocarbons; flame retardants; persistent organic pollutants such as per- and poly-fluoroalkyl substances; polybrominated diphenyl ethers; and polychlorinated dibenzo-p-dioxins, furans, and biphenyls; and chemicals added to consumer and personal-care products such as phthalates and phenols (e.g., bisphenol A, triclosan, parabens). Antonia has developed and maintained extensive collaborative research with leading scientists in the fields of exposure science, epidemiology, toxicology, and health assessment, and has co-authored more than 350 peer-reviewed publications. Her research has made relevant contributions to CDC’s biomonitoring program including the CDC’s National Reports on Human Exposure to Environmental Chemicals.
  Antonio Hugo Jose Froes Marques Campos, MD, PhD
Dr. Antonio Hugo Campos is a pathologist, master and doctor in Oncology. He is currently the head of the A. C. Camargo Cancer Center Biobank in Sao Paulo, Brazil. He has served as member of the A. C. Camargo Cancer Center IRB, member of the Working Group on Biobanks for the preparation of the Ministry of Health Ordinance 2201/2011, member of the National Commission for Research Ethics (CONEP), and advisor of the Integrated Network of DNA Databanks of the Ministry of Justice.
  Yali Cong, PhD
Yali Cong was trained in Biology in Beijing Normal University and Philosophy in People’s University, China. She has been involved in research and teaching at Peking University Health Science Center (PUHSC) since she received her PhD in 1995. She teaches medical ethics to clinical medical students and supervises graduate students. After the SARS outbreak in Beijing, she and her colleagues at the school of public health in PUHSC initiated a public health ethics program. Since 2010, she has been the Chair of IRB and is working with other leaders to establish the first Human Subject Protection Program at Peking University. In 2008, she set up a joint center for medical professionalism with IMAP and the University of Columbia. She serves as the vice chair of the China Medical Ethics Association, and is a member of a number of international organizations, including WHO and IAB. She has published 50 papers in English and Chinese.
  Georges Dagher, PhD
Georges Dagher, senior investigator (Directeur de Recherche) at Inserm (Paris, France) accomplished most of his career in pathophysiological and clinical research at Necker Hospital (1979-1984), College de France (1985-1993) and Faculty of medicine Broussais-Hotel Dieu (1994-2004). He joined the physiological laboratory (Cambridge, UK) for a post-doc fellowship (1983-85) and was a special guest to physiological laboratory, Harvard Medical School (Boston, US, 1982, 1984). Georges Dagher published about 100 papers in international peer-reviewed journals on hypertension, arterial hypertrophy, obesity and lipid metabolism, manic depression, renal physiology, and transmembrane ion transport. He was the director of BIOBANQUES infrastructure (Inserm US 13), a French infrastructure that regroups 85 biobanks (2012-2017); the coordinator of biological resources centres at Inserm (2006); the director of clinical research infrastructures at Inserm (2006-2009) and the deputy director of the department of clinical research at the Public Health Institute, Inserm, France (2009-2011). He participated actively to the preparatory phase of the pan-European Biobanking and Biomolecular Research Infrastructure (BBMRI-ERIC). In this preparatory phase he was a leading figure of the coordination committee and the leader of a work package on funding and financing. Later, when the infrastructure was set up as an ERIC, he was the vice chair of the Assembly of Members and member of the coordination body. He is also a member of BIOSHARE and BBMRI- LPS within the 7th EU framework program. He contributed to the OECD best practice guidelines for biological resource centres and the OECD guidelines on human biobanks and genetic databases. He participated in the elaboration of the French norm for biobanks NF S96-900 norm and the convenor of an ISO committee drafting an international standard for biobanking. He is a delegate of several French institutions to European and international committees or meetings (OECD, ESF, ERA, ALLEA, EASAC…) and a number of expert committees focusing on the issues related to biobanks within Europe and internationally. He is an expert to the Austrian Federal Ministry of science and research (BMWF) and Genome Quebec. He was also a member of the Inserm ethics committee (ERMES) and the Institutional Review Board (IRB).
  Petr Holub, PhD
Dr. Holub is associate professor of computer science at Masaryk University. Since 2015, he has become senior IT/data protection manager with BBMRI-ERIC, European Research Infrastructure Consortium for Biobanking and BioMolecular Resources and CIO of BBMRI-ERIC common service IT. He has background both in sciences and computer science. He was head of the dept. of communication technologies at the Institute of Computer Science, Masaryk University, as well as architect of advanced multimedia and collaborative systems of the Czech national e-infrastructure at CESNET. His research in computer networks and multimedia processing has lead to more than 40 research papers in established computer science journals and ranked conferences.
  Bartha Maria Knoppers, PhD
Bartha Maria Knoppers, PhD (Comparative Medical Law), is a Professor and Director of the Centre of Genomics and Policy, Faculty of Medicine, Human Genetics, McGill University.

She holds the Canada Research Chair in Law and Medicine and is the founder of the Population Project in Genomics (P3G) and CARTaGENE, Quebec’s population biobank. Chair of the Ethics Working Party of the International Stem Cell Forum (2005-2015); Co-Chair of the Sampling/ELSI Committee of the 1000 Genomes Project (2007-2014); Chair of the Ethics and Governance Council of the International Cancer Genome Consortium (2009-17 ); and Co-Chair of the Regulatory and Ethics Working Group of the Global Alliance for Genomics and Health.

Dr. Knoppers is the recipient of four Doctorates Honoris Causa, she is Fellow of the American Association for the Advancement of Science (AAAS), the Hastings Center (bioethics), the Canadian Academy of Health Sciences (CAHS) and, in 2016, was named Fellow of the Royal Society of Canada. She is also an Officer of the Order of Canada and of Quebec.

  Lena Krieger
Being a project manager at DIN since 2012, Dipl.-Ing. Lena Krieger is the Secretary of ISO Technical Committee 276 "Biotechnology" and its working group “Biobanks and bioresources”; she is also Secretary of the European CEN Technical Committee 140 “In vitro diagnostic medical devices”, and thus responsible for the development of medical and biotechnological standards as well as the coordination of cross-sectorial topics in these areas. She participated in the FP 7 SPIDIA project, is leading the standardization work package in the European SPIDIA4P Project, and is currently bringing the research results into European and international standardization.
  Joakim Lundeberg
Professor Joakim Lundeberg heads the division of gene technology, KTH based at the Science for Life Laboratory. The current research focus of Joakim relates to spatially resolved gene expression studies, spatial transcriptomics (Ståhl et al, Science, 2016), and single cell sequencing (Vickovic et al, Nature Comm, 2016). In the work recently published a method is described that allows studies of gene expression in tissue sections using RNA-sequencing to uncover transcriptional patterns in situ. Joakim also heads the National Genomics Infrastructure that has a staff of >70 full time employees which renders NGI as one of the largest sequencing centers in Europe.
  Dan Milner, MD, MSc
Dan Milner, MD, MSc, Chief Medical Officer, ASCP: Dr. Milner completed his MD at the University of Alabama School of Medicine in 2000 and his residency/fellowship in anatomic pathology/clinical pathology/microbiology at the Brigham and Women’s Hospital in 2005. Before joining ASCP, Dr. Milner spent 10 years as faculty at Harvard where he taught pathology, microbiology, and infectious disease, was the primary lead for infectious disease consultations in AP/CP, and was the recipient of numerous research grants in the areas of malaria and HIV. In addition to these accomplishments, Dr. Milner began working in Africa in 1997 as a medical student and has built an international reputation as an expert in cerebral malaria. In parallel with this, he has been heavily involved in pathology capacity building in many countries and, most notably, lead the team that built an anatomic pathology laboratory in Rwanda and Haiti for advance cancer diagnostics. In his current role, he serves as the Director for the Center for Global Health at ASCP, leads all PEPFAR activities with ASCP (lab strengthening, x 5+ countries), and leads the Cancer Diagnosis and Treatment in Africa Initiative (telepathology, 20+ countries). Dr. Milner is the author of over 100 publications and has presented nationally and internationally on his work in more than 15 countries.
  Keymanthri Moodley, MD, MBA
Keymanthri Moodley is a Professor in the Department of Medicine and Director of the Centre for Medical Ethics and Law, Department of Medicine, Faculty of Health Sciences, Stellenbosch University. In 2017, she was appointed Adjunct Professor, Department of Social Medicine, University of North Carolina-Chapel Hill, USA. Keymanthri is a family physician who currently works as a bioethicist. In 2013 she was rated by the National Research Foundation (NRF) as an established researcher based on her numerous national and international publications, conference presentations, her role on national bodies like the MRC Board and the National Health Research Ethics Council (NHREC), and her involvement in international organisations such as the World Health Organisation (WHO), International AIDS Society (IAS), and NIH DSMBs. She has worked as principal investigator on clinical trials since 1999, and served on the University Research Ethics Committee (REC) for 10 years. The Centre that she has directed for the past 14 years was designated as a Collaborating Centre in Bioethics by the WHO, one of seven in the world and the first on the African continent. The main activities of the Centre include bioethics teaching, empirical research in bioethics and clinical ethics consultation. Since 2011, Keymanthri has co-hosted an NIH Fogarty program to develop capacity in Health Research Ethics in Africa in collaboration with the Bioethics Center, University of North Carolina-Chapel Hill, USA. This program has graduated 40 postgraduate scholars from 10 African countries over the past 4 years. In 2013 she was awarded a second NIH grant to examine the ethical and social issues associated with HIV Cure research. In 2015 the Centre was awarded its third NIH grant to explore ethical, legal, and social issues related to genomic biobanking. Keymanthri is a member of the Academy of Science in South Africa. She completed an Executive MBA in 2015. Since November 2016 she has chaired the REC of the South African Medical Research Council and qualified as an Associate Executive Coach in the same year. In 2017 she was awarded her 4th NIH grant to develop a Leadership Program in Bioethics. This will include a doctoral program in Clinical and Research Ethics – the first NIH funded program of its kind based in Africa. Keymanthri was recently appointed as a member of the Scientific Advisory Committee of the European and Developing Countries Clinical Trials Program (EDCTP). She has 2 sons, Kehar (25) and Nikhal (20). In her leisure time she enjoys gardening, dancing, and mindfulness practices.
  Helen Moore, PhD
Dr. Helen Moore leads the NCI Biorepositories and Biospecimen Research Branch (BBRB). As Chief she sets the direction and strategic vision for the Branch and oversees a complex set of projects related to biobanking, including: The NCI Best Practices for Biospecimen Resources, a foundational document for biobanking in use internationally; a biospecimen science research program to develop the evidence for biospecimen best practices; the Biospecimen Research Database, a web-based biospecimen science literature database; research in the ethical, legal, and social implications of biobanking; and biobanking operations for major NCI and NIH programs including the NIH Genotype-Tissue Expression (GTEx) Program. Dr. Moore previously led BBRB's Biospecimen Research Network (BRN). She speaks internationally about BBRB and biobanking, publishes articles related to BBRB and related initiatives, and serves as expert reviewer and member of advisory boards. Dr. Moore is a molecular biologist with a broad background in research and development. She came to the NCI from Celera Genomics. Dr. Moore earned her doctorate at Cornell University and her BA at Wellesley College.
  Margaretha Persson, RN, MSc, PhD
Margaretha Persson is associate professor in Cardiovascular Epidemiology at the University of Lund since 2016 and is co-principal investigator of SCAPIS. She is also head of the clinical research unit at Malmö University Hospital since 2002.
She is a registered nurse with a master degree in public health, and gained her PhD in Cardiovascular Epidemiology in 2008.
  Nilsa C. Ramirez, MD, FCAP
Nilsa C. Ramirez, MD, FCAP is the advisor and former chair of the College of American Pathologists Biorepository Accreditation Program (CAP BAP) Committee, regional commissioner of the CAP BAP, and a member of the CAP Surgical Pathology Committee. She is a pathologist, Director of the Biopathology Center and of the Autopsy Division at Nationwide Children’s Hospital, and a professor of clinical pathology at the Ohio State University in Columbus, OH, USA. Her expertise includes biobanking in the context of adult and pediatric cancer clinical trials.
  Heng-Phon Too, PhD
Dr. Too Heng Phon received his undergraduate training in Biochemistry, Imperial College of Science & Technology, UK. He then continued with his PhD training in a joint research project at Imperial College, Institute of Ophthalmology and West Minister Hospital, London. Thereafter, he received further training with the Medical Research Council, Cambridge (UK), where he was a Procter & Gamble Fellow. He then moved to the Department of Anesthesiology and Department of Biological Chemistry & Molecular Pharmacology, Harvard Medical School where he was a recipient of the Merck Sharpe Dohme Academic Development Fellowship. Currently, he is a faculty member in the Department of Biochemistry, National University Singapore, an Adjunct Scientist in the Bioprocess Technological Institute, and a Fellow of the Singapore Massachusetts Institute of Technology Alliance (Molecular Engineering of Biological & Chemical Systems program; Chemical & Pharmaceutical Engineering program). Dr. Too is a molecular biologist focusing on biotechnology and neuroscience. In recent years, Roche Diagnostics (USA & Asia Pacific) and the National Institute of Health (USA) funded him to develop qPCR assays for infectious diseases. He is an awardee of a number of commercialization of technology grants from A*STAR and Singapore-Massachusetts Research & Technology (SMART). Dr. Too has collaborated on the co-development of IVD for prognostic/diagnostic for breast cancer. He is the founder of MiRXES in Singapore. He has intellectual property protections on specific diagnostic platforms with various research departments and with Massachusetts Institute of Technology, USA.
  Daniel Simeon-Dubach, MD, MHA
Daniel Simeon-Dubach, MD, MHA is the owner of Medservice, a biobanking consulting and service company located in Walchwil, Switzerland. He earned both his MD and his Master of Health Administration (MHA) from the University of Bern, Switzerland. He has been in biobanking for more than 10 years. His research and publication focus is in biobank sustainability, biomedical reproducibility, process and quality management, as well as collaboration between academia and industry. He has co-organized and co-chaired a series of symposia on sustainability at different ISBER annual meetings. He has conducted several surveys amongst biobankers on issues of collaboration and on sustainability.
He is in the marketing committee for the GBW 2017 in Stockholm. He is chair of ISBER Standards Advisory Committee. He has served on the ISBER program committees over the past few years and is a member of the ISBER program committee for 2018. He is section editor for biobanking management of the journal Biopreservation and Biobanking and member of the editorial board of the journal Synergy.
  Peter Watson, MB, BChir, FRCPC
Peter Watson, MB, BChir, FRCPC, is Professor of Pathology and Staff Pathologist and Senior Scientist at the BC Cancer Agency, British Columbia, Canada. He is the Director of Biobanking and Biospecimen Research Services (BBRS) which is a research infrastructure group that encompasses an active biobank and biobanking support unit (Tumour Tissue Repository (BCCA-TTR) at the BC Cancer Agency and Office of Biobank Education and Research (UBC-OBER) at the Department of Pathology, University of British Columbia). Our goals are to support the establishment of small and large biobanks for biospecimen based translational research and promote access, quality, and standardization through delivery of education and training and communication of best practices. He also leads the Canadian Tissue Repository Network (CTRNet) and is deputy editor for Biopreservation and Biobanking, the journal of the International Society for Biological and Environmental Repositories (ISBER). Over the past 30 years he has maintained an active clinical pathology practice focused on breast cancer and a research laboratory program focused on elucidating mechanisms of progression, understanding the intratumoral immune response, and identifying biomarkers to guide response to therapies in breast cancer. He is author of over 180 research and biobanking publications.
  Kurt Zatloukal, MD
Kurt Zatloukal, MD, is professor of pathology at the Medical University of Graz, Austria. His research focuses on molecular pathology of diseases as well as biobanking and related data management technologies. He coordinated the preparatory phase of the European Biobanking and Biomolecular Research Infrastructure (BBMRI-ERIC) and is director of the Austrian national node of BBMRI. He is also coordinator of a national digital pathology infrastructure, which is linked to biobanks. He is member of the Academia Europaea, has published 213 scientific papers, and was co-inventor of 25 patent applications.